As it is standard for all robotaxi developers, the initial focus will be on manually mapping the new cities before any autonomous testing takes place
Click for Full Disclaimer What to Expect From a GLP-1 Therapy Program A clear, provider-guided process focused on safety, support, and steady progress
It is a stimulant and acts similarly to amphetamine
Early results from ongoing clinical studies are indicating the GLP-1 medications may successfully treat numerous other conditions including non-alcoholic fatty liver disease (known as metabolic dysfunction-associated steatohepatitis or MASH), sleep apnea, heart failure, diabetic kidney disease and Alzheimers disease
Earlier-phase studies indicated that the drug may help reduce liver fat in people with obesity, potentially slowing the progression of NAFLD
In a study published in the Journal of the American Medical Association Psychiatry, people with alcohol use disorder who took a low dose of semaglutide cut their consumption by roughly 50% more than those taking a placebo